Back to Search
Start Over
Table S7 from PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination Therapy
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Phosphopeptide changes induced by PQR309 in B cell lymphoma cell lines revealed using mass spectrometry analysis.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....0db1f7156367b31bcff38259ba1acd43